Search

Search Results
Results 4711 - 4720 of 4752 for multiple sclerosis
  • Top challenges: 15th Clinical Biomarkers & CDx Summit Europe
    White Paper - 6 Mar 2025
    Discover the top challenges tackled at Hanson Wade's 15th Clinical Biomarkers & CDx Summit Europe
  • Expanding new trends and technologies in ADC therapeutics
    White Paper - 18 Feb 2025
    Explore the latest advancements and innovative technologies in ADC therapeutics, driving new possibilities for targeted drug delivery.
  • Diaformin (AF)
    Drug - 17 Dec 2024
    Consumer Medicine Information (CMI) about Diaformin (AF) intended for persons living in Australia.
  • Clofen
    Drug - 5 Nov 2024
    Consumer Medicine Information (CMI) about Clofen intended for persons living in Australia.
  • Opsynvi
    Drug - 30 Sep 2024
    Consumer Medicine Information (CMI) about Opsynvi intended for persons living in Australia.
  • Xatral SR
    Drug - 25 Sep 2024
    Consumer Medicine Information (CMI) about Xatral SR intended for persons living in Australia.
  • Orencia
    Drug - 29 Aug 2024
    Consumer Medicine Information (CMI) about Orencia intended for persons living in Australia.
  • Perisyl
    Drug - 16 Aug 2024
    Consumer Medicine Information (CMI) about Perisyl intended for persons living in Australia.
  • Diaformin Viatris
    Drug - 15 Aug 2024
    Consumer Medicine Information (CMI) about Diaformin Viatris intended for persons living in Australia.
  • Itracap
    Drug - 27 Jun 2024
    Consumer Medicine Information (CMI) about Itracap intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback